跳至主要内容
临床试验/NCT06548022
NCT06548022已完成不适用

Rare Group Problem Management Plus

Children's National Research Institute1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2024年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
8
试验地点
1
主要终点
Acceptability

研究概览

简要总结

Participants are being asked to be in the study if they are the parent or legal guardian of a child (>1 year or <18 years old) with a rare condition.

The group based psychoeducational intervention is called Rare Group Problem Management Plus.

Rare Group PM Plus may help adults with practical and emotional problems. It is a group program (there will be other men or women with similar problems) It happens once a week for 5 weeks (each session lasts 90 minutes)

Participants will complete assessments before they start Rare Group PM+. Participants will also complete the same assessments within a few weeks of completing Rare Group PM+. Assessments should only take one hour.

Study visits are by Telemedicine. Participants will need a smart phone or tablet. If they do not have a smart phone or tablet, the study team will help with this.

Participants will not receive any materials or money or medication.

详细描述

Participants are being asked to be in the study because they are the parent or legal guardian of a child (infancy up to 21 years old) with a rare condition.

The group based psychoeducational intervention is called Rare Group Problem Management (PM) Plus intervention.

Rare Group PM Plus may help adults with practical and emotional problems It is a group program (there will be other men or women with similar problems) It happens once a week for 5 weeks (each session lasts 90 minutes)

Investigators will be recruiting for 3 groups of 10 families each, for a total of 30 families who will participate in this study from Children's National Hospital.

There are 7 study visits.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Family caregiver aged 18 years or older of a child with a rare disease from infancy to age 21 years.
  • Understands and speaks English or Spanish. Reading or health literacy is not required.
  • Signed consent.
  • Signed waiver of assent for child.

排除标准

  • Family caregiver is under the age of 18 years.
  • Child with the rare disease is over the age of 21 years.
  • Family caregiver is actively suicidal, homicidal, or psychotic.
  • Family caregiver is impaired (cognitively or by drugs or alcohol).
  • Family caregiver has a low level of distress.

结局指标

主要结局

Acceptability

时间窗: 2 weeks post-intervention (Session 5)

As measured by retention at 2 weeks post-intervention assessment

次要结局

未报告次要终点

研究者

发起方
Children's National Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maureen Lyon

Clinical Health Psychologist

Children's National Research Institute

研究点 (1)

Loading locations...

相似试验

Rare Group Problem Management Plus | 临床试验